|
AP1822A
(en)
*
|
2002-02-14 |
2008-01-30 |
Pharmacia Corp |
Substituted pyridinones as modulators of P38 MAP kinase.
|
|
US7456222B2
(en)
*
|
2002-05-17 |
2008-11-25 |
Sequella, Inc. |
Anti tubercular drug: compositions and methods
|
|
CN101404986B
(zh)
*
|
2002-05-17 |
2011-09-28 |
赛奎拉公司 |
用于诊断和治疗感染性疾病的组合物和制药方法
|
|
US20040033986A1
(en)
*
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
|
EP1405849A1
(en)
*
|
2002-10-04 |
2004-04-07 |
Corning Incorporated |
Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
|
|
CL2004002050A1
(es)
*
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
EP1670314A4
(en)
*
|
2003-09-05 |
2009-02-25 |
Sequella Inc |
METHODS AND COMPOSITIONS INCLUDE DIAMINE AS A NEW THERAPEUTIC FOR TUBERCULOSIS
|
|
US7825133B2
(en)
*
|
2003-11-14 |
2010-11-02 |
Shanghai Genomics, Inc. |
Derivatives of pyridone and the use of them
|
|
KR101190912B1
(ko)
*
|
2003-11-19 |
2012-10-12 |
어레이 바이오파마 인크. |
Ｍｅｋ의 헤테로시클릭 억제제 및 그의 사용 방법
|
|
EP2228369A1
(en)
|
2003-12-23 |
2010-09-15 |
Astex Therapeutics Ltd. |
Pyrazole derivatives as protein kinase modulators
|
|
US7732456B2
(en)
|
2004-03-05 |
2010-06-08 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone derivative
|
|
JPWO2005105743A1
(ja)
*
|
2004-04-28 |
2008-03-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
|
JP4853759B2
(ja)
*
|
2004-05-27 |
2012-01-11 |
日本農薬株式会社 |
置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
|
|
TWI355380B
(en)
|
2004-05-27 |
2012-01-01 |
Nihon Nohyaku Co Ltd |
Substituted pyrazinecarboxanilide derivatives or s
|
|
AU2005273612B2
(en)
|
2004-08-12 |
2010-10-14 |
Pfizer Inc. |
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1802590A1
(en)
*
|
2004-10-13 |
2007-07-04 |
Pharmacia & Upjohn Company LLC |
Substituted n-alkylpyrimidinones
|
|
US7713998B2
(en)
|
2004-11-10 |
2010-05-11 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic compound and pharmaceutical use thereof
|
|
EP1838675A1
(en)
*
|
2004-11-24 |
2007-10-03 |
Laboratoires Serono S.A. |
Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
|
|
ATE537164T1
(de)
|
2004-12-21 |
2011-12-15 |
Merck Serono Sa |
Zyklische sulfonylaminoderivate und deren verwendung als mmp-hemmer
|
|
ATE516279T1
(de)
|
2005-01-31 |
2011-07-15 |
Merck Serono Sa |
N-hydroxyamidderivate und ihre verwendung
|
|
AP2007004244A0
(en)
|
2005-05-10 |
2007-12-31 |
Intermune Inc |
Method of modulating stress-activated protein kinase system
|
|
US8343953B2
(en)
|
2005-06-22 |
2013-01-01 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
WO2006136837A2
(en)
|
2005-06-23 |
2006-12-28 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
|
TW200740755A
(en)
*
|
2005-07-13 |
2007-11-01 |
Bayer Cropscience Sa |
Dihalogenation of N,O-disubstituted hydroxypyridones and their uses
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
US7875633B2
(en)
*
|
2005-08-24 |
2011-01-25 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
JP5112317B2
(ja)
*
|
2005-08-29 |
2013-01-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
|
|
WO2007027729A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
|
AU2006285038A1
(en)
|
2005-08-29 |
2007-03-08 |
Vertex Pharmaceuticals Incorporated |
3,5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases
|
|
EP1933860A2
(en)
|
2005-09-01 |
2008-06-25 |
Ares Trading S.A. |
Treatment of optic neuritis
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
US7973060B2
(en)
*
|
2005-10-13 |
2011-07-05 |
Crystalgenomics, Inc. |
Fab I inhibitor and process for preparing same
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US7718830B2
(en)
|
2006-04-24 |
2010-05-18 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
CA2823724A1
(en)
|
2006-04-24 |
2007-11-08 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
US7618966B2
(en)
|
2006-04-24 |
2009-11-17 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
PE20080150A1
(es)
*
|
2006-06-02 |
2008-04-11 |
Janssen Pharmaceutica Nv |
Derivados de piridinona n-aril y n-heteroaril sustituidos como antagonistas del receptor de la hormona concentradora de melanina (mch)
|
|
DE602007010287D1
(de)
*
|
2006-06-05 |
2010-12-16 |
Novartis Ag |
Organische verbindungen
|
|
AU2007272830B2
(en)
*
|
2006-07-14 |
2011-07-28 |
Amgen Inc. |
Alkyne-substituted pyridone compounds and methods of use
|
|
JP5073746B2
(ja)
|
2006-08-25 |
2012-11-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｍｃｈ拮抗作用を有する新規ピリドン誘導体及びこの化合物を含む薬物
|
|
WO2008041090A1
(en)
*
|
2006-10-06 |
2008-04-10 |
Pfizer Limited |
Malanin concentrating hormone receptor-1 antagonist pyridinones
|
|
CA2671984A1
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim International Gmbh |
New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
|
|
KR20090090379A
(ko)
*
|
2006-12-13 |
2009-08-25 |
화이자 프로덕츠 인크. |
3-(4-(2,4-디플루오로벤질옥시)-3-브로모-6-메틸-2-옥소피리딘-1(2ｈ)-일)-ｎ,4-디메틸벤즈아미드의 제조 방법
|
|
US20100210649A1
(en)
*
|
2006-12-21 |
2010-08-19 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
|
MX2009007336A
(es)
*
|
2007-01-10 |
2009-07-15 |
Albany Molecular Res Inc |
Indazoles substituidos con 5-furopiridinona.
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
AU2008265595B2
(en)
|
2007-06-20 |
2014-12-04 |
PureTech LYT 100 Inc. |
Substituted N-Aryl pyridinones as fibrotic inhibitors
|
|
PL2170864T3
(pl)
*
|
2007-07-17 |
2012-02-29 |
Bristol Myers Squibb Co |
Agoniści receptora gpr119 sprężonego z białkiem g - pirydon
|
|
EA017648B1
(ru)
|
2007-09-14 |
2013-02-28 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
|
|
BRPI0816970A2
(pt)
|
2007-09-14 |
2015-03-24 |
Ortho Mcneil Janssen Pharm |
1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
|
|
TW200922566A
(en)
|
2007-09-14 |
2009-06-01 |
Ortho Mcneil Janssen Pharm |
1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
|
|
AR070950A1
(es)
*
|
2007-11-01 |
2010-05-19 |
Acucela Inc |
Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
|
|
CA2704436C
(en)
|
2007-11-14 |
2016-01-05 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN101952274A
(zh)
*
|
2007-11-20 |
2011-01-19 |
默沙东公司 |
非核苷逆转录酶抑制剂
|
|
US20090281054A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Venkata Reddy |
Compositions and methods comprising capuramycin analogues
|
|
EP2296653B1
(en)
|
2008-06-03 |
2016-01-27 |
Intermune, Inc. |
Compounds and methods for treating inflammatory and fibrotic disorders
|
|
JP5547194B2
(ja)
|
2008-09-02 |
2014-07-09 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
|
|
GEP20135793B
(en)
|
2008-09-11 |
2013-03-25 |
Pfizer |
Heteroaryls amide derivatives and their use as glucokinase activators
|
|
WO2010043396A1
(en)
|
2008-10-16 |
2010-04-22 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
JP2012515760A
(ja)
|
2009-01-20 |
2012-07-12 |
ファイザー・インク |
置換ピラジノンアミド
|
|
WO2010103437A1
(en)
|
2009-03-11 |
2010-09-16 |
Pfizer Inc. |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
HRP20131122T1
(hr)
|
2009-05-12 |
2013-12-20 |
Janssen Pharmaceuticals, Inc. |
Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
|
|
CN102439015B
(zh)
|
2009-05-12 |
2015-05-13 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
|
|
EP2474533B1
(en)
|
2009-05-25 |
2015-02-25 |
Central South University |
Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
|
|
CN102149682B
(zh)
|
2009-05-25 |
2012-12-05 |
中南大学 |
1-(取代芳基)-5-三氟甲基-2-（1h）吡啶酮化合物及其盐的制备方法及其用途
|
|
US20110021570A1
(en)
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
CN101973936B
(zh)
*
|
2010-09-28 |
2012-02-08 |
太原理工大学 |
一种吡啶酮衍生物的制备方法
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
JP5852664B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
US9359300B2
(en)
|
2010-12-06 |
2016-06-07 |
Confluence Life Sciences, Inc. |
Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
DK2648516T3
(da)
*
|
2010-12-06 |
2019-01-02 |
Aclaris Therapeutics Inc |
Substituerede pyridinon-pyridinylforbindelser
|
|
US8507499B2
(en)
|
2010-12-06 |
2013-08-13 |
Confluence Life Sciences, Inc. |
Substituted indole/indazole-pyrimidinyl compounds
|
|
US8563558B2
(en)
|
2010-12-06 |
2013-10-22 |
Confluence Life Sciences, Inc. |
Substituted pyridine urea compounds
|
|
AP3336A
(en)
*
|
2011-03-07 |
2015-07-31 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
BR112013022766A2
(pt)
|
2011-03-08 |
2016-12-06 |
Auspex Pharmaceuticals Inc |
método de administração de d-pirfenidona e kit
|
|
AU2012301953C1
(en)
*
|
2011-08-29 |
2016-11-03 |
Ptc Therapeutics, Inc. |
Antibacterial compounds and methods for use
|
|
BR112014004832A2
(pt)
*
|
2011-08-29 |
2017-04-04 |
Ptc Therapeutics Inc |
compostos antibacterianos e métodos para uso
|
|
EP2768826A1
(de)
*
|
2011-10-17 |
2014-08-27 |
Bayer Intellectual Property GmbH |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
BR112014012288A2
(pt)
|
2011-11-22 |
2017-05-23 |
Intermune Inc |
métodos para diagnosticar e tratar fibrose pulmonar idiopática
|
|
US9056110B2
(en)
|
2011-12-06 |
2015-06-16 |
Confluence Life Sciences, Inc. |
Substituted pyrimidinone-phenyl-pyrimidinyl compounds
|
|
WO2013093484A1
(en)
|
2011-12-21 |
2013-06-27 |
Ono Pharmaceutical Co., Ltd. |
Pyridinone and pyrimidinone derivatives as factor xia inhibitors
|
|
US9365540B2
(en)
*
|
2012-01-12 |
2016-06-14 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivatives as MCH receptor antagonists
|
|
PE20150666A1
(es)
*
|
2012-03-01 |
2015-05-06 |
Array Biopharma Inc |
Inhibidores de serina/treonina cinasa
|
|
CN103288719A
(zh)
*
|
2012-03-05 |
2013-09-11 |
苏州欧凯医药技术有限公司 |
非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
|
|
JP5924984B2
(ja)
*
|
2012-03-06 |
2016-05-25 |
国立大学法人東京農工大学 |
トリフルオロメチルピリジノン化合物およびその製造方法
|
|
US9434695B2
(en)
|
2012-07-18 |
2016-09-06 |
Sunshine Lake Pharma Co., Ltd |
Nitrogenous heterocyclic derivatives and their application in drugs
|
|
WO2014031928A2
(en)
*
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
DK2888255T3
(en)
|
2012-08-24 |
2018-10-29 |
Univ Texas |
HETOCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
AU2013359273B2
(en)
|
2012-12-13 |
2016-04-14 |
Ravinder Reddy Kondreddi |
Pyridone derivatives and uses thereof in the treatment of tuberculosis
|
|
CN105026373B
(zh)
*
|
2013-01-31 |
2018-03-30 |
沃泰克斯药物股份有限公司 |
作为钠通道调节剂的吡啶酮酰胺
|
|
WO2014181213A1
(en)
|
2013-05-10 |
2014-11-13 |
Pfizer Inc. |
Crystalline form of (sa)-(-)-3-(3-bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1 (2h)-yl)-n,4-dimethylbenzamide
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
KR102313515B1
(ko)
|
2013-06-07 |
2021-10-14 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
메틸/플루오로-피리디닐-메톡시 치환된 피리디논-피리디닐 화합물 및 플루오로-피리미디닐-메톡시 치환된 피리디논-피리디닐 화합물
|
|
UY35650A
(es)
|
2013-07-09 |
2015-02-27 |
Takeda Pharmaceutical |
Compuesto heterocíclico
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
SG11201604477SA
(en)
|
2013-12-13 |
2016-07-28 |
Vertex Pharma |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
PL3096790T3
(pl)
|
2014-01-21 |
2020-01-31 |
Janssen Pharmaceutica, N.V. |
Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
|
|
WO2015130790A2
(en)
|
2014-02-25 |
2015-09-03 |
Board Of Regents, University Of Texas System |
Salts of heterocyclic modulators of hif activity for treatment of disease
|
|
RU2692485C2
(ru)
|
2014-04-02 |
2019-06-25 |
Интермьюн, Инк. |
Противофиброзные пиридиноны
|
|
DK3174852T3
(en)
*
|
2014-07-30 |
2018-09-10 |
Abac Therapeutics S L |
ARYL HYDRAZIDES CONTAINING A 2-PYRIDON PART AS SELECTIVE ANTIBACTERIALS
|
|
WO2016093285A1
(ja)
|
2014-12-10 |
2016-06-16 |
小野薬品工業株式会社 |
ジヒドロインドリジノン誘導体
|
|
HRP20191327T1
(hr)
*
|
2015-06-03 |
2019-11-01 |
Bristol Myers Squibb Co |
4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja
|
|
CN105153027A
(zh)
*
|
2015-07-21 |
2015-12-16 |
东华大学 |
一种3-氰基-4-羟基-2-吡啶酮类化合物及其制备和应用
|
|
CN106466318B
(zh)
*
|
2015-08-21 |
2019-01-01 |
中南大学 |
1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
|
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
|
KR102714561B1
(ko)
|
2017-05-16 |
2024-10-10 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 중수소화 피리돈 아미드 및 이의 프로드럭
|
|
KR102236356B1
(ko)
|
2017-11-24 |
2021-04-05 |
주식회사 종근당 |
루푸스의 예방 또는 치료를 위한 조성물
|
|
US20190343817A1
(en)
|
2018-02-12 |
2019-11-14 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
|
KR20190099952A
(ko)
*
|
2018-02-20 |
2019-08-28 |
주식회사 종근당 |
포도막염의 예방 또는 치료를 위한 조성물
|
|
JP7646643B2
(ja)
*
|
2019-10-04 |
2025-03-17 |
アンスティトゥート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシャルシュ・メディカル・（インセルム） |
新規なピリジン－２（１ｈ）オン誘導体、その調製、及び疼痛を処置するためのその使用
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
GB201918413D0
(en)
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
|
|
IL296054A
(en)
|
2020-03-27 |
2022-10-01 |
Aclaris Therapeutics Inc |
Oral compositions of mk2 pathway inhibitor for treatment of immune conditions
|
|
JP2021183587A
(ja)
|
2020-05-22 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN112552232B
(zh)
*
|
2020-12-16 |
2022-11-25 |
浙江工业大学 |
一种吡啶酮六位炔胺修饰衍生物及其制备方法与应用
|
|
KR20230153387A
(ko)
|
2021-02-02 |
2023-11-06 |
리미널 바이오사이언시스 리미티드 |
Gpr84 길항제 및 이의 용도
|
|
JP2024506858A
(ja)
|
2021-02-02 |
2024-02-15 |
リミナル・バイオサイエンシーズ・リミテッド |
Ｇｐｒ８４アンタゴニストおよびその使用
|
|
WO2022212489A1
(en)
*
|
2021-03-31 |
2022-10-06 |
Xinthera, Inc. |
Mk2 inhibitors and uses thereof
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
US11685719B2
(en)
|
2021-07-09 |
2023-06-27 |
Xinthera, Inc. |
Pyridinone MK2 inhibitors and uses thereof
|
|
CN116444493A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海翰森生物医药科技有限公司 |
含双并环类衍生物、其制备方法和应用
|
|
WO2024022412A1
(zh)
*
|
2022-07-28 |
2024-02-01 |
深圳信立泰药业股份有限公司 |
一种式(i)所示的三联吡啶二酮化合物晶型及其制备方法与应用
|